A simple, ex vivo phagocytosis assay of Plasmodium vivax merozoites by flow cytometry

AUTOR(ES)

Farias, Elizangela

FONTE

Mem. Inst. Oswaldo Cruz

DATA DE PUBLICAÇÃO

07/10/2019

RESUMO

As phagocytosis is the first line of defense against malaria, we developed a phagocytosis assay with Plasmodium vivax (P. vivax) merozoites that can be applied to evaluate vaccine candidates. Briefly, after leukocyte removal with loosely packed cellulose powder in a syringe, P. vivax trophozoites matured to the merozoite-rich schizont stages in the presence of the E64 protease inhibitor. The Percoll gradient-enriched schizonts were chemically disrupted to release merozoites that were submitted to merozoite opsonin-dependent phagocytosis in two phagocytic lines with human and mouse antibodies against the N- and C-terminus of P. vivax Merozoite Surface Protein-1 (Nterm-PvMSP1 and MSP119). The resulting assay is simple and efficient for use as a routine phagocytic assay for the evaluation of merozoite stage vaccine candidates.

Documentos Relacionados

• Opsonization and Phagocytosis of Plasmodium falciparum Merozoites Measured by Flow Cytometry
• Trypan blue exclusion assay by flow cytometry
• Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry.
• Comparison of a Classical Phagocytosis Assay and a Flow Cytometry Assay for Assessment of the Phagocytic Capacity of Sera from Adults Vaccinated with a Pneumococcal Conjugate Vaccine
• A Simple, Sensitive Protein-binding Assay for Guanosine 3′:5′-Monophosphate